US Stock MarketDetailed Quotes

ENLV Enlivex Therapeutics

Watchlist
  • 1.300
  • 0.0000.00%
Close Dec 4 16:00 ET
28.59MMarket Cap-1326P/E (TTM)

Enlivex Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Enlivex Therapeutics Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 2 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2024/Q4-- / 0.000--
--2024/Q30.000 / 0.000--
--2024/Q20.000 / 0.000--
--2024/Q10.000 / 0.000--
--2023/Q40.000 / 0.000--
DatePeriodRevenue/EstimateEarnings Call
--2024/Q4-- / 0.000--
--2024/Q30.000 / 0.000--
--2024/Q20.000 / 0.000--
--2024/Q10.000 / 0.000--
--2023/Q40.000 / 0.000--

Unlock Free Earnings Estimates

Enlivex Therapeutics Earnings Reports

  • Enlivex Therapeutics | 6-K: Report of foreign private issuer (related to financial reporting)

    Nov 29 16:34 ET

  • Enlivex Therapeutics | 6-K/A: Report of foreign private issuer (related to financial reporting)

    Oct 15 06:17 ET

  • Enlivex Therapeutics | 6-K: Report of foreign private issuer (related to financial reporting)

    Sep 11 08:31 ET

  • Enlivex Therapeutics | 6-K: Report of foreign private issuer (related to financial reporting)

    Aug 30 16:34 ET

    • Read more

    Analysis

    Analyst Rating

    Updated: Nov 30, 2024

    Buy

    • Buy

      100.00%

    • Hold

      0.00%

    • Sell

      0.00%

    Price Target

    No Data

    Heat List
    US
    Overall
    Symbol
    Latest Price
    % Chg

    No Data

    Investment Theme Top Gainers Yesterday
    Top Gainers Yesterday
    Intraday-1.34%